[Interdisciplinary recommendations on targeted therapy in the treatment of renal cell carcinoma]. / Interdisziplinäre Therapieempfehlungen zur Behandlung des metastasierten Nierenzellkarzinoms.
Aktuelle Urol
; 38(4): 328-30, 2007 Jul.
Article
em De
| MEDLINE
| ID: mdl-17647172
ABSTRACT
Recently, new data have been published on the treatment of metastasized renal cell cancer using targeted therapies. With the approval of the tyrosine kinase inhibitors Sunitinib and Sorafenib, two of these new therapies are now available in clinical practice. This has raised both new opportunities and new questions for the health care professionals involved. Here we report on a consensus conference addressing these questions with answers based on evidence from the recent literature.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Piridinas
/
Pirróis
/
Benzenossulfonatos
/
Carcinoma de Células Renais
/
Inibidores de Proteínas Quinases
/
Indóis
/
Neoplasias Renais
/
Antineoplásicos
Tipo de estudo:
Clinical_trials
/
Guideline
/
Prognostic_studies
/
Systematic_reviews
Limite:
Humans
Idioma:
De
Ano de publicação:
2007
Tipo de documento:
Article